top of page
Call Toll Free : 1 (855) MEDVIN-1
Scleroderma or Systemic Sclerosis
About this study... 48 week study plus possible extension study
PARTICIPATION CRITERIA
Must show evidence of active disease within 2 years
Worsening of skin thickening
Must be on a stable dose of concomitant treatment for SSC
PARTICIPATING LOCATIONS
Apple Valley, Riverside, Menifee, Covina, Whittier, Tujunga
Compensation
Earn up to $1,000 for 13 visits in a year
Medications
New Investigational drug with Novel pathway to treat the disease
Duration
1 year study (13 office visits) followed by possibly an Open label extension study with no placebo
bottom of page